Editorial outlines how green nanotechnology enhances drug delivery systems, suggesting new regulatory guidelines and industry partnerships.
Green nanotechnology entails the combination of nanoscience, green chemistry, and sustainable engineering in order to develop safe, energy-saving, and biodegradable drug delivery systems. Green systems, unlike traditional nanomaterials that rely on toxic solvents and high en-ergy inputs, involve the use of plant extracts, natural polymers, and environmentally friendly pro-cesses to produce biocompatible nanocarriers. This editorial provides insight into how green nan-otechnology can be used to enhance pharmaceutical innovation as a way of solving sustainability, safety, and regulatory issues. It goes on to highlight that the world regulators (FDA, EMA, CDSCO) should develop sustainability-specific guidelines and increase partnership between aca-demia and industry. Green nanotechnology has the ability to transform the face of pharmaceutics to a more patient-centered and environmentally friendly environment by integrating sustainability measures and encouraging collaboration within the industry.
No takes yet. Share an insight, caveat, or question.
Vikal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: